Clinical Trial Update: Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Kesuting Syrup for COVID-19 pneumonia and cough has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Cough

Drugs mentioned

• Kesuting Syrup

Snippet

Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd | Conditions: COVID-19 Pneumonia, Cough | Phase 4 | Status: COMPLETED